Autoimmune Encephalitis

Lukapalooza Costume Bash to Benefit AEA November 13, 2017

The inaugural Lukapalooza Costume Bash to benefit the AE Alliance was a great success and is in the books! Luke Shriver, an AE survivor, and his family and friends had an amazing time while sharing awareness and raising funds for the AE Alliance.  The spirit of community, courage, and the love of good music brought a […]

May is AEA Research Network Month: What is it? May 2, 2022

AEA Research Network Month is when the AE Alliance focuses on research funding, collaborations and AE research awareness. What’s our goal? Raise funds for the 2023 Seed Grant Program. Provide you, the AEA Community a strong understanding of the huge importance of research and AE. What can you expect during May 2022? A better understanding […]

Antibody associations in 2750 children with suspected autoimmune encephalitis February 12, 2024

Making the diagnosis of autoimmune encephalitis (AE) can be very straightforward when the patient develops features that are highly characteristic of a particular AE. For example, a 30-year old woman with new onset psychiatric symptoms such as hallucinations or strange behaviors and who also has repetitive movements around their mouth in their face (known as […]

Dr. Hesham Abboud – Symptomatic Management of Autoimmune Encephalitis March 3, 2025

Many thanks to Dr. Hesham Abboud, MD, PhD, for joining our May 2025 AEA Provider Monthly Education Series and presenting on symptomatic management of autoimmune encephalitis. Dr. Abboud is the Director of Neuroimmunology at University Hospitals Cleveland Medical Center and Associate Professor of Neurology at Case Western Reserve University. He founded and currently runs a specialized autoimmune encephalitis […]

New treatment for anti-NMDAR autoimmune encephalitis reports Charité – Universitätsmedizin Berlin February 2, 2017

One of the one of the largest university hospitals in Europe, Charite’, recorded significant progress in treating anti-NMDAR, including in patients who did not previously respond to treatment. Anti-NMDA receptor encephalitis is an inflammatory disease that affects the central nervous system. It is a rare autoimmune disease that results in the body producing antibodies against […]

Targeted Therapy Holds Future Promise July 9, 2017

In many areas of medicine, treatments are increasingly becoming targeted in a way that benefits patients. This is happening in fields ranging from oncology to neurological disease. In this month’s Neurology Now, treatment for autoimmune encephalitis is being cited as one area where “precision medicine” holds promise for better and targeted treatments according to antibody […]

Dr. Josep Dalmau Receives Prestigious Award for Research in Autoimmune Brain Disease November 6, 2017

Pioneer in the field of autoimmune encephalitis, Josep Dalmau was recently honored with the prestigious Rey Jaime I Award for medical research in a ceremony in Barcelona, Spain. His group’s achievements are in the area of autoimmune disorders that affect the brain, including the recognition of several new syndromes in autoimmune encephalitis. They are credited […]

Why Research Network Month? A Conversation with Caterri Woodrum & Meg Poe May 4, 2022

The Research Network launched in May, 2020 and resulted in the first AEA Community Seed Grant Program in 2021. This program supports research focused on the diagnosis, management, and outcomes of individuals with AE. The program is funded by members, friends and supporters of the AE Alliance Community. Would you like to know the answers […]

Neurologic, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.  March 12, 2024

A recently published study is providing a close look at anti-LGI1 encephalitis which, after anti-NMDA receptor encephalitis, is the second most common autoimmune encephalitis. Anti-LGI1 encephalitis most often affects middle aged patients who come to medical attention because of the quick onset (over a few weeks to a few months) of memory loss. Less commonly […]

Meet Dr. Yuri Shisido August 8, 2025

Dr. Yuri Shisido (Emory University, Atlanta, Georgia, USA) was awarded a 2025 AEA Community Seed Grant for the investigation of Patient-Centered Assessment of Everyday Cognitive Function in Children with Pediatric Anti- NMDA Receptor Encephalitis with Novel MRI Biomarkers. Learn more about her research and how it will impact those affected with autoimmune encephalitis. The start date […]